Can Fujifilm’s EB-710US simplify lung cancer staging procedures in the United States?
EBUS imaging is clinically valuable, but workflow remains messy. Fujifilm’s EB-710US tests whether simpler design can change adoption.
Medical Devices & Diagnostics
Medical Devices & Diagnostics
Veracyte’s TrueMRD Medicare win pushes whole-genome MRD testing into bladder cancer surveillance
MRD testing is moving from research to reimbursement. Veracyte now has Medicare coverage, but adoption in bladder cancer care is the harder test.
Medical Devices & Diagnostics
Mevion’s European expansion gains momentum with Southern Italy proton therapy project
Proton therapy is precise but hard to scale. Mevion’s Naples win tests whether compact systems can shift access across Southern Europe.
Medical Devices & Diagnostics
What Natera’s Signatera CDx approval changes for adjuvant Tecentriq use in bladder cancer
MRD testing just crossed into treatment selection. Natera’s Signatera FDA win could reshape adjuvant bladder cancer care.
Medical Devices & Diagnostics
Genentech’s Tecentriq decision puts Natera’s Signatera at the centre of precision bladder cancer care
Bladder cancer treatment is becoming more selective. Tecentriq’s ctDNA-guided approval may redefine who gets adjuvant immunotherapy.
Medical Devices & Diagnostics
Why Novanta’s June healthcare conference appearance matters after its Q1 revenue rebound
Medtech suppliers are under pressure to prove growth quality. Novanta’s Jefferies appearance may sharpen the investor debate.
Medical Devices & Diagnostics
Why BlueWind Medical’s $47.8m raise matters for the next phase of UUI treatment
UUI devices have clinical momentum. BlueWind Medical’s next challenge is proving Revi can scale through access, reimbursement, and workflow adoption.
Medical Devices & Diagnostics
Is Butterfly Medical’s prostate retraction device the next challenger in minimally invasive BPH treatment?
BPH care needs options beyond pills and surgery. Butterfly Medical’s $21m raise puts its reversible prostate implant in the spotlight.
Medical Devices & Diagnostics
Why Glooko’s FDA-cleared EndoTool IV Cloud could reshape hospital glycemic management
Insulin dosing is moving to the cloud. Glooko’s FDA clearance raises bigger questions on hospital workflow, safety, and scale.
Medical Devices & Diagnostics
Can Aridol give Arna Pharma and Slate Run a sharper entry into U.S. respiratory diagnostics?
Specialty pharma needs sharper U.S. routes to market. Arna Pharma and Slate Run are testing that model with Aridol and 505(b)(2) products.